Randomized and controlled study of the effects of low intensity monochromatic 'blue light' compared to the standard light treatment of seasonal complaints (winter depression and winterblues)

Randomized and controlled study of the effects of low intensity monochromatic 'blue light' compared to the standard light treatment of seasonal complaints (winter depression and winterblues) - monochromatic blue light vs standard light treatment in seasonal complaints

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON34402

Enrollment

100

Registered

2010-11-18

Start date

2010-11-24

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

seasonal affective disorder (winter type) winterblues

Interventions

Experimental treatment is exposure to low intensity blue monochromatic light, compared to standard light treatment

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age between 18-65 yr - no other treatments for seasonal complaints during the same time - no traveling to southern counties during study period - no use of tanning fixtures during study period - informed consent;1. seasonal affective disorder (SAD), winter type, according to DSM-IV score of at least 18 on the first 24 items of the SIGH-SAD 2. sub-syndromal seasonal affective disorder (sub-SAD, winterblues) acording to the Kasper et al. (1988) criteria: - SPAQ-GSS score of 8,9 or 10 and at least light seasonal complaints or - SPAQ-GSS score of 11 score of 12-17 on the first 24 items of the SIGH-SAD

Exclusion criteria

Exclusion criteria: other Axis -I disorders according to DSM-IV acute suicidal risk use of pschopharmaca or photosensitsizing drugs eye diseases or complaints exept aging diabetes epilepsy night shifts

Design outcomes

Primary

Measure	Time frame
Sores on the SIGH-SAD interviews	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)